ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,915.62
-0.25%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Arcellx Inc (ACLX)

  7. Arcellx Inc (ACLX) Noticias

ACLX

Arcellx (ACLX)

Arcellx Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ACLX
FechaHoraFuenteTítuloSímboloCompañía
09/05/202415:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACLXArcellx Inc
09/05/202415:05Business WireKite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma ProgramNASDAQ:ACLXArcellx Inc
09/05/202415:05Business WireArcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma ProgramNASDAQ:ACLXArcellx Inc
09/05/202415:00Business WireArcellx Provides First Quarter 2024 Financial ResultsNASDAQ:ACLXArcellx Inc
07/05/202415:00Business WireArcellx to Participate in Two Upcoming Investor ConferencesNASDAQ:ACLXArcellx Inc
04/04/202415:00Business WireArcellx to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:ACLXArcellx Inc
20/03/202415:00Business WireArcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceNASDAQ:ACLXArcellx Inc
07/03/202417:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACLXArcellx Inc
29/02/202415:00PR Newswire (US)Arcellx to Participate at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:ACLXArcellx Inc
28/02/202415:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACLXArcellx Inc
28/02/202415:00PR Newswire (US)Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business HighlightsNASDAQ:ACLXArcellx Inc
14/02/202416:57Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACLXArcellx Inc
12/02/202418:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACLXArcellx Inc
02/01/202415:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ACLXArcellx Inc
18/12/202315:16Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ACLXArcellx Inc
08/12/202315:00PR Newswire (US)Arcellx Announces Continued Robust Long-Term Responses from Its CART-ddBCMA (anito-cel) Phase 1 Expansion Trial in Patients with Relapsed or Refractory Multiple Myeloma at ASHNASDAQ:ACLXArcellx Inc
15/11/202307:30Dow Jones NewsArcellx Shares Rise Premarket on Expanded Gilead CollaborationNASDAQ:ACLXArcellx Inc
15/11/202305:58Dow Jones NewsGilead Invests Further in Arcellx, Extends CollaborationNASDAQ:ACLXArcellx Inc
15/11/202305:00PR Newswire (US)ARCELLX AND KITE ANNOUNCE EXPANSION IN STRATEGIC PARTNERSHIPNASDAQ:ACLXArcellx Inc
15/11/202305:00Business WireKite and Arcellx Announce Expansion in Strategic PartnershipNASDAQ:ACLXArcellx Inc
13/11/202315:00PR Newswire (US)Arcellx Provides Third Quarter 2023 Financial Results and Business HighlightsNASDAQ:ACLXArcellx Inc
02/11/202308:00PR Newswire (US)Arcellx Announces Oral Presentation for Its CART-ddBCMA Phase 1 Trial in Patients with Relapsed or Refractory Multiple Myeloma at the 65th ASH Annual Meeting and ExpositionNASDAQ:ACLXArcellx Inc
14/08/202315:00PR Newswire (US)Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1 Phase 2 Clinical Program and Reports Second Quarter Financial ResultsNASDAQ:ACLXArcellx Inc
21/07/202315:44Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACLXArcellx Inc
23/06/202313:32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ACLXArcellx Inc
20/06/202305:57Dow Jones NewsArcellx Shares Drop After Patient Death Draws Clinical Hold from FDANASDAQ:ACLXArcellx Inc
19/06/202318:46PR Newswire (US)Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical ProgramNASDAQ:ACLXArcellx Inc
16/06/202315:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACLXArcellx Inc
31/05/202317:14Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ACLXArcellx Inc
09/05/202315:09Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:ACLXArcellx Inc
 Showing the most relevant articles for your search:NASDAQ:ACLX

Su Consulta Reciente

NYSE
VZ
Verizon Communications
FX
EURMXN
Euro vs MXN
NASDAQ
NVDA
NVIDIA
AMEX
XLE
Energy Select Sector SPDR
CCOM
OILBRENT
Brent Oil
AMEX
SPY
SPDR S&P 500
COIN
SOLUSD
Solana
NYSE
AXP
American Express
NASDAQ
AMZN
Amazon.com
COIN
BTCUSD
Bitcoin
SPI
SP500
S&P 500
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
CVX
Chevron
NYSE
XOM
Exxon Mobil
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados